Assessment of Dose Proportionality and the Effect of Food on a Once-Daily Extended-Release Tablet Formulation of Deutetrabenazine in Healthy Participants.
Saved in:
| Title: | Assessment of Dose Proportionality and the Effect of Food on a Once-Daily Extended-Release Tablet Formulation of Deutetrabenazine in Healthy Participants. |
|---|---|
| Authors: | Sunzel EM; Innovative Medicines R&D Global Clinical Development, Teva Pharmaceuticals, 145 Brandywine Parkway, West Chester, PA, 19380, USA., Ghibellini G; Innovative Medicines R&D Global Clinical Development, Teva Pharmaceuticals, 145 Brandywine Parkway, West Chester, PA, 19380, USA., Gutierrez M; Teva Clinics, Miramar, FL, USA., Ruffo D; Innovative Medicines R&D Global Clinical Development, Teva Pharmaceuticals, 145 Brandywine Parkway, West Chester, PA, 19380, USA., Chavan S; Watson Pharma Pvt. Ltd. Seawoods, Navi-Mumbai, Maharashtra, India., Birajdar NG; Watson Pharma Pvt. Ltd. Seawoods, Navi-Mumbai, Maharashtra, India., Schneider F; Teva Pharmaceutical Industries Ltd, Ratiopharm GmbH, Ulm, Germany., Loupe P; Innovative Medicines R&D Global Clinical Development, Teva Pharmaceuticals, 145 Brandywine Parkway, West Chester, PA, 19380, USA. Pippa.Loupe@Tevapharm.com., Gordon MF; Innovative Medicines R&D Global Clinical Development, Teva Pharmaceuticals, 145 Brandywine Parkway, West Chester, PA, 19380, USA., Rabinovich-Guilatt L; Innovative Medicines R&D Global Clinical Development, Teva Pharmaceuticals, Netanya, Israel. |
| Source: | Clinical drug investigation [Clin Drug Investig] 2026 Aug; Vol. 46 (8), pp. 911-923. Date of Electronic Publication: 2026 Jun 19. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9504817 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1918 (Electronic) Linking ISSN: 11732563 NLM ISO Abbreviation: Clin Drug Investig Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42321496 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Assessment of Dose Proportionality and the Effect of Food on a Once-Daily Extended-Release Tablet Formulation of Deutetrabenazine in Healthy Participants. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sunzel+EM%22">Sunzel EM</searchLink>; Innovative Medicines R&D Global Clinical Development, Teva Pharmaceuticals, 145 Brandywine Parkway, West Chester, PA, 19380, USA.<br /><searchLink fieldCode="AU" term="%22Ghibellini+G%22">Ghibellini G</searchLink>; Innovative Medicines R&D Global Clinical Development, Teva Pharmaceuticals, 145 Brandywine Parkway, West Chester, PA, 19380, USA.<br /><searchLink fieldCode="AU" term="%22Gutierrez+M%22">Gutierrez M</searchLink>; Teva Clinics, Miramar, FL, USA.<br /><searchLink fieldCode="AU" term="%22Ruffo+D%22">Ruffo D</searchLink>; Innovative Medicines R&D Global Clinical Development, Teva Pharmaceuticals, 145 Brandywine Parkway, West Chester, PA, 19380, USA.<br /><searchLink fieldCode="AU" term="%22Chavan+S%22">Chavan S</searchLink>; Watson Pharma Pvt. Ltd. Seawoods, Navi-Mumbai, Maharashtra, India.<br /><searchLink fieldCode="AU" term="%22Birajdar+NG%22">Birajdar NG</searchLink>; Watson Pharma Pvt. Ltd. Seawoods, Navi-Mumbai, Maharashtra, India.<br /><searchLink fieldCode="AU" term="%22Schneider+F%22">Schneider F</searchLink>; Teva Pharmaceutical Industries Ltd, Ratiopharm GmbH, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Loupe+P%22">Loupe P</searchLink>; Innovative Medicines R&D Global Clinical Development, Teva Pharmaceuticals, 145 Brandywine Parkway, West Chester, PA, 19380, USA. Pippa.Loupe@Tevapharm.com.<br /><searchLink fieldCode="AU" term="%22Gordon+MF%22">Gordon MF</searchLink>; Innovative Medicines R&D Global Clinical Development, Teva Pharmaceuticals, 145 Brandywine Parkway, West Chester, PA, 19380, USA.<br /><searchLink fieldCode="AU" term="%22Rabinovich-Guilatt+L%22">Rabinovich-Guilatt L</searchLink>; Innovative Medicines R&D Global Clinical Development, Teva Pharmaceuticals, Netanya, Israel. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229504817%22">Clinical drug investigation</searchLink> [Clin Drug Investig] 2026 Aug; Vol. 46 (8), pp. 911-923. <i>Date of Electronic Publication: </i>2026 Jun 19. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9504817 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1918 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211732563%22">11732563 </searchLink><i>NLM ISO Abbreviation: </i>Clin Drug Investig <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42321496 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s40261-026-01566-8 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 911 Titles: – TitleFull: Assessment of Dose Proportionality and the Effect of Food on a Once-Daily Extended-Release Tablet Formulation of Deutetrabenazine in Healthy Participants. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sunzel EM – PersonEntity: Name: NameFull: Ghibellini G – PersonEntity: Name: NameFull: Gutierrez M – PersonEntity: Name: NameFull: Ruffo D – PersonEntity: Name: NameFull: Chavan S – PersonEntity: Name: NameFull: Birajdar NG – PersonEntity: Name: NameFull: Schneider F – PersonEntity: Name: NameFull: Loupe P – PersonEntity: Name: NameFull: Gordon MF – PersonEntity: Name: NameFull: Rabinovich-Guilatt L IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2026 Aug Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1179-1918 Numbering: – Type: volume Value: 46 – Type: issue Value: 8 Titles: – TitleFull: Clinical drug investigation Type: main |
| ResultId | 1 |